116 related articles for article (PubMed ID: 11451628)
1. Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization.
Joshi M; Misra A
Int J Pharm; 2001 Jul; 223(1-2):15-27. PubMed ID: 11451628
[TBL] [Abstract][Full Text] [Related]
2. Liposomal budesonide for dry powder inhaler: preparation and stabilization.
Joshi MR; Misra A
AAPS PharmSciTech; 2001 Nov; 2(4):25. PubMed ID: 14727862
[TBL] [Abstract][Full Text] [Related]
3. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung.
Joshi M; Misra A
Clin Exp Pharmacol Physiol; 2003 Mar; 30(3):153-6. PubMed ID: 12603343
[TBL] [Abstract][Full Text] [Related]
4. Development of liposomal amphotericin B dry powder inhaler formulation.
Shah SP; Misra A
Drug Deliv; 2004; 11(4):247-53. PubMed ID: 15371106
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary disposition of budesonide from liposomal dry powder inhaler.
Joshi M; Misra AN
Methods Find Exp Clin Pharmacol; 2001 Dec; 23(10):531-6. PubMed ID: 11957743
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance.
Shah SP; Misra A
AAPS PharmSciTech; 2004 Aug; 5(4):e65. PubMed ID: 15760062
[TBL] [Abstract][Full Text] [Related]
7. Development of liposomal salbutamol sulfate dry powder inhaler formulation.
Huang WH; Yang ZJ; Wu H; Wong YF; Zhao ZZ; Liu L
Biol Pharm Bull; 2010; 33(3):512-7. PubMed ID: 20190418
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis.
Chennakesavulu S; Mishra A; Sudheer A; Sowmya C; Suryaprakash Reddy C; Bhargav E
Asian J Pharm Sci; 2018 Jan; 13(1):91-100. PubMed ID: 32104382
[TBL] [Abstract][Full Text] [Related]
9. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity.
Ourique AF; Chaves Pdos S; Souto GD; Pohlmann AR; Guterres SS; Beck RC
Eur J Pharm Sci; 2014 Dec; 65():174-82. PubMed ID: 25263567
[TBL] [Abstract][Full Text] [Related]
10. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
Chougule MB; Padhi BK; Misra A
J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation.
Tang Y; Zhang H; Lu X; Jiang L; Xi X; Liu J; Zhu J
Drug Deliv; 2015; 22(5):608-18. PubMed ID: 24299495
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
Changsan N; Chan HK; Separovic F; Srichana T
J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
14. Liposomal dry powders as aerosols for pulmonary delivery of proteins.
Lu D; Hickey AJ
AAPS PharmSciTech; 2005 Dec; 6(4):E641-8. PubMed ID: 16408866
[TBL] [Abstract][Full Text] [Related]
15. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach.
Patil-Gadhe A; Pokharkar V
Pulm Pharmacol Ther; 2014 Apr; 27(2):197-207. PubMed ID: 23916767
[TBL] [Abstract][Full Text] [Related]
16. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
[TBL] [Abstract][Full Text] [Related]
17. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B dry powder inhaler: effect of fines on in vitro performance.
Shah SP; Misra A
Pharmazie; 2004 Oct; 59(10):812-3. PubMed ID: 15544064
[TBL] [Abstract][Full Text] [Related]
19. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]